LincRNA-ROR/miR-145/ZEB2 regulates liver fibrosis by modulating HERC5-mediated p53 ISGylation

The tumor suppressor p53 has been implicated in the pathogenesis of liver fibrosis. HERC5-mediated posttranslational ISG modification of the p53 protein is critical for controlling its activity. Here, we demonstrated that the expression of HERC5 and ISG15 is highly elevated, whereas p53 is downregulated, in fibrotic liver tissues of mice and transforming growth factor-beta 1 (TGF-beta 1)-induced LX2 cells. HERC5 siRNA clearly increased the protein expression of p53, but the mRNA expression of p53 was not obviously changed. The inhibition of lincRNA-ROR (ROR) downregulated HERC5 expression and elevated p53 expression in TGF-beta 1-stimulated LX-2 cells. Furthermore, the expression of p53 was almost unchanged after TGF-beta 1-stimulated LX-2 cells were co-transfected with a ROR-expressing plasmid and HERC5 siRNA. We further confirmed that miR-145 is a target gene of ROR. In addition, we also showed that ROR regulates the HERC5-mediated ISGylation of p53 through mir-145/ZEB2. Together, we propose that ROR/miR-145/ZEB2 might be involved in the course of liver fibrosis by regulating ISGylation of the p53 protein.

Automated summary

The expression of HERC5 and ISG15 is increased, while p53 is decreased, in fibrotic liver tissues and TGF-beta 1-induced LX2 cells. Inhibition of HERC5 leads to increased protein expression of p53, but no obvious change in mRNA expression. Furthermore, lincRNA-ROR regulates HERC5-mediated ISGylation of p53 through miR-145/ZEB2. This suggests that ROR/miR-145/ZEB2 may play a crucial role in the development of liver fibrosis.